Abstract
Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) are two debilitating health disorders afflicting millions worldwide. Recent research has revealed similarities between AD and T2DM. Both these protein conformational disorders are associated with obesity, insulin resistance, inflammation and endoplasmic reticulum stress, en-route initiation and/or stage aggravation. In this mini review we have tried to summarize studies describing obesity, insulin resistance and glucocorticoid imbalance as common patho-mechanisms in T2DM and AD. A reduction in tyrosine hydroxylase (TH) in the brain has been found to occur in Parkinson’s disease (PD). AD, T2DM and PD share common risk factors like depression. Thus, whether TH is involved in the ‘state of cognitive depression’ that is the hallmark of AD and often accompanies PD and T2DM is also explored.
Keywords: Type 2 diabetes mellitus, Alzheimer’s disease, Parkinson’s disease, neurodegeneration, tyrosine hydroxylase, dementia, obesity, insulin resistance, metabolic syndrome, neuroinflammation.
CNS & Neurological Disorders - Drug Targets
Title:Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase
Volume: 11 Issue: 4
Author(s): Medha Priyadarshini, Mohammad A. Kamal, Nigel H. Greig, Marcella Realef, Adel M. Abuzenadah, Adeel G.A. Chaudhary and Ghazi A. Damanhouri
Affiliation:
Keywords: Type 2 diabetes mellitus, Alzheimer’s disease, Parkinson’s disease, neurodegeneration, tyrosine hydroxylase, dementia, obesity, insulin resistance, metabolic syndrome, neuroinflammation.
Abstract: Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) are two debilitating health disorders afflicting millions worldwide. Recent research has revealed similarities between AD and T2DM. Both these protein conformational disorders are associated with obesity, insulin resistance, inflammation and endoplasmic reticulum stress, en-route initiation and/or stage aggravation. In this mini review we have tried to summarize studies describing obesity, insulin resistance and glucocorticoid imbalance as common patho-mechanisms in T2DM and AD. A reduction in tyrosine hydroxylase (TH) in the brain has been found to occur in Parkinson’s disease (PD). AD, T2DM and PD share common risk factors like depression. Thus, whether TH is involved in the ‘state of cognitive depression’ that is the hallmark of AD and often accompanies PD and T2DM is also explored.
Export Options
About this article
Cite this article as:
Priyadarshini Medha, A. Kamal Mohammad, H. Greig Nigel, Realef Marcella, M. Abuzenadah Adel, G.A. Chaudhary Adeel and A. Damanhouri Ghazi, Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase, CNS & Neurological Disorders - Drug Targets 2012; 11 (4) . https://dx.doi.org/10.2174/187152712800792767
DOI https://dx.doi.org/10.2174/187152712800792767 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial: [Hot Topic: Establishment of the Australian Infectious Diseases Research Centre]
Current Drug Targets Ivabradine: Cardiovascular Effects
Recent Patents on Cardiovascular Drug Discovery Assessing Systemic Arterial Hypertension Through Echocardiography: A Review for the Clinician
Current Hypertension Reviews Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists
Current Drug Targets Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Editorial [Hot Topic: Tailor-Made Solutions and Multidirectional Approach in the Combat of Degenerative Pathologies (Executive Guest Editor: Anna Karewicz)]
Current Pharmaceutical Design Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
Current Vascular Pharmacology GSK3 Inhibitors and Disease
Mini-Reviews in Medicinal Chemistry Hyperandrogenism, Insulin Resistance and Hyperinsulinemia as Cardiovascular Risk Factors in Diabetes Mellitus
Current Diabetes Reviews Cardiac Biomarkers in the Identification of Future Risk in Chronic Obstructive Pulmonary Disease
Current Topics in Medicinal Chemistry Intimal Hyperplasia in Murine Models
Current Drug Targets MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
Current Genomics Disorders of Innate Immunity in Human ageing and effects of Nutraceutical Administration
Endocrine, Metabolic & Immune Disorders - Drug Targets Decreased Vascular Repair and Neovascularization with Ageing: Mechanisms and Clinical Relevance with an Emphasis on Hypoxia- Inducible Factor-1
Current Molecular Medicine Bioactive Proteins and Peptides from Soybeans
Recent Patents on Food, Nutrition & Agriculture Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease
Current Cardiology Reviews Adipose Tissue as a Regulator of Energy Balance
Current Drug Targets Cardiovascular Disease Risk of Type 2 Diabetes Mellitus and Metabolic Syndrome: Focus on Aggressive Management of Dyslipidemia
Current Diabetes Reviews Pharmacogenomics in Drug Induced Liver Injury
Current Drug Metabolism Atrial Fibrillation in Heart Failure: An Innocent Bystander?
Current Cardiology Reviews